The Antiphospholipid Antibody Syndrome Research in Patients with Retinal Venous Occlusion

Background tiphospholipid antibody syndrome (APAS) is a condition associated with abnormal thrombosis and the presence of anticardiolipin antibodies (aCL). s -two patients (20 male and 12 female) aged between 29 and 75 years (mean ± SD: 56.4 ± 12.34) with retinal venous occlusive disease were studied. All patients with a history of venous occlusive disease within the previous 8 months were included in the study. Diagnoses were made by fundus examination and fundus fluorescein angiography (FFA). Anticardiolipin IgM and IgG antibodies, antinuclear antibodies (ANA), and IL-1β were investigated in all patients. s r aCL-IgM nor aCL-IgG was observed as positive in this group. Only four patients were found to be ANA positive. However, serum levels of IL-1β were higher than those of controls (p <0.001). Mean IL-1β was found to be 18.06 ± 3.39 pg/mL (mean ± SE), respectively. IL-1β levels were found to be significantly different from those of controls (2.7 ± 0.68 pg/mL) (p <0.001). In this study, antiphospholipid antibody positivity was not determined in any patients. sions esult, IL-1β level appears higher in retinal venous occlusive disease. This cytokine measurement might be used as a diagnostic indicator for venous occlusive disease.